Posterior Lateral Fusion (PLF) With Dynesys

NCT ID: NCT00791180

Last Updated: 2011-09-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

38 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-03-31

Study Completion Date

2011-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary purpose of this study is to track and document the clinical outcomes of patients with radicular pathology following posterior lateral fusion with the Dynesys Spinal System. Secondary purpose of this study is to assess outcomes with historical controls along a continuum of motion and anatomy sparing procedures.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will help the patient to the extent that it will allow the comparison of this unique treatment to the corpus of literature on radicular pathology, thus focusing a specific treatment for a specific pathology.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spondylolisthesis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Spondylolisthesis of less than Grade II at the index level (degenerative with intact pars)
* Will receive a decompression for lumbar stenosis
* Symptoms of leg and/or back pain
* One pathological level
* Between the ages of 20 and 80 at the time of surgery
* Non-responsive to non-surgical treatment for at least six months

Exclusion Criteria

* Osteolytic spondylolisthesis
* Planned complete facetectomy
* Two or more pathological levels (and as enumerated int he Dynesys Spinal system instructions for use)
* Use in the cervical spine
* Active systemic or local infection
* Extreme obesity as defined by a Body Mass Index (BMI)over 40. BMI calculated using Appendix A, adapted from the National Heart, Lung, and Blood Institute, Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults.
* Pregnancy
* Mental illness
* Severe osteoporosis or osteopenia. The World Health Organization defines osteoporosis as BMD\<-2.5t. Professional discretion should be used and if bone quality is in question a DEXA scan is recommended.
* Sensitivities/allergy to metals, polymers, polyethylene, polycarbonate urethane and polyethylene terephthalate
* Alcohol or drug abuse
* Patient unwilling or unable to follow postoperative instructions
* Soft tissue deficit not allowing sound closure
* Any medical or physical condition that would preclude the potential benefit of spinal surgery
* Inadequate pedicles of the lumbar or sacral vertebrae; congenital abnormalities, tumors or other conditions that would prevent secure component fixation that has the potential to decrease the useful life of othe devices;
* Any medical or mental condition which would exclude the patient at high risk from surgery of the severity
Minimum Eligible Age

20 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zimmer Biomet

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jozef Murar, M.D.

Role: STUDY_DIRECTOR

Zimmer Spine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Foundation Surgical Hospital

Houston, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2006-002

Identifier Type: -

Identifier Source: org_study_id